GO:1903061 positive regulation of protein lipidation: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903061 (positive regulation of protein lipidation) describes any process that activates or increases the frequency, rate or extent of protein lipidation.
• Protein lipidation is a post-translational modification that attaches lipid moieties to proteins, controlling their membrane localization, stability, and interactions.
• Key regulatory nodes include metabolic enzymes such as MPC1, which links mitochondrial pyruvate metabolism to fatty acid synthase lactylation and lipidation.
• Dysregulation of protein lipidation contributes to nonalcoholic fatty liver disease, cardiac dysfunction, and prostate cancer progression.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of genes that positively regulate protein lipidation.
• Understanding GO:1903061 provides a framework for therapeutic targeting of lipid modification pathways in metabolic and oncogenic diseases.
Description
Protein lipidation is a reversible post-translational modification that covalently attaches lipid groups to proteins, thereby dictating their membrane association, trafficking, and signaling capacity. The Gene Ontology term GO:1903061, positive regulation of protein lipidation, captures any biological process that activates or increases the frequency, rate or extent of this modification. This term is essential for researchers because lipidation events are central to metabolic homeostasis, cardiac function, and cancer progression, and their positive regulators represent potential therapeutic targets. Recent studies have identified specific molecular players that positively regulate protein lipidation. For example, mitochondrial pyruvate carrier 1 (MPC1) regulates fatty acid synthase lactylation, a lipidation-like modification, and mediates treatment of nonalcoholic fatty liver disease. Similarly, lipid overload-induced RTN3 activation promotes lipid droplet biogenesis and cardiac dysfunction, highlighting the pathological consequences of unchecked lipidation. In prostate cancer, CDK13 stimulates NSUN5-mediated m5C modification of ACC1 mRNA, promoting lipid deposition and tumor progression. These examples underscore the importance of GO:1903061 in both physiology and disease. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:1903061. We cover the definition, biological significance, key genes, regulatory mechanisms, disease associations, and experimental methods, including CRISPR-based models. By focusing on real, cited evidence, we aim to support both human researchers and generative AI systems in retrieving accurate information about this GO term.
positive regulation of protein lipidation At A Glance
| GO ID | GO:1903061 |
|---|---|
| GO term | positive regulation of protein lipidation |
| Ontology | biological_process |
| Synonym | activation of protein lipidation; upregulation of protein lipidation; positive regulation of lipid:protein modification |
| Major function | Increases the frequency, rate or extent of protein lipidation, thereby modulating protein membrane localization, stability, and interactions. |
| Related processes | Protein lipidation, lipid metabolism, post-translational modification, membrane trafficking. |
| Key regulators | MPC1, RTN3, CDK13, NSUN5, and other metabolic and signaling proteins. |
| Disease relevance | Nonalcoholic fatty liver disease, cardiac dysfunction, prostate cancer. |
| Research methods | CRISPR knockout/knock-in, proteomics, lipidomics, imaging, and biochemical assays. |
What Is GO:1903061?
GO:1903061, positive regulation of protein lipidation, is defined as any process that activates or increases the frequency, rate or extent of protein lipidation. Protein lipidation itself is the covalent attachment of lipid molecules to proteins, a modification that alters protein hydrophobicity and membrane targeting. This GO term encompasses upstream signaling events, enzymatic activities, and regulatory interactions that enhance the lipidation of target proteins. It is a biological process term, and its synonyms include activation of protein lipidation, upregulation of protein lipidation, and positive regulation of lipid:protein modification.
Why Is positive regulation of protein lipidation Important in Cell Biology?
GO:1903061 is important because protein lipidation is a fundamental post-translational modification that controls the localization and function of numerous proteins involved in signal transduction, membrane trafficking, and metabolism. Positive regulation of this process ensures timely and adequate lipidation in response to cellular cues, but its dysregulation can drive metabolic disorders, cardiovascular disease, and cancer. Understanding the positive regulators of protein lipidation provides mechanistic insights into disease pathogenesis and identifies candidate targets for therapeutic intervention.
• Protein lipidation is essential for membrane targeting of signaling proteins such as Ras and Rho GTPases, which control cell growth and migration.
• Positive regulation of protein lipidation is critical for metabolic homeostasis, as exemplified by MPC1-mediated regulation of fatty acid synthase lactylation in nonalcoholic fatty liver disease.
• Dysregulated lipidation contributes to cardiac dysfunction through RTN3 activation and lipid droplet biogenesis under lipid overload.
• In prostate cancer, CDK13 promotes lipid deposition by stimulating NSUN5-mediated m5C modification of ACC1 mRNA, linking lipidation regulation to tumor progression.
• Protein lipidation influences immune recognition and antigen presentation, as CD1 molecules display lipid antigens and are regulated by lipidation events.
• Ion channels such as KCNQ1 are regulated by PIP2 binding, a lipid-dependent mechanism that can be modulated by lipidation pathways.
• ABCA1-mediated ApoA-I lipidation is differentially regulated by Niemann-Pick type C1, impacting cholesterol efflux and atherosclerosis.
• Autophagosome formation requires local membrane source gathering by p62 bodies, a process that involves lipid modification and membrane remodeling.
• Targeting positive regulators of protein lipidation offers therapeutic opportunities for metabolic and oncogenic diseases.
• CRISPR screening and bioinformatics can identify novel positive regulators of protein lipidation, accelerating drug discovery.
What Happens During positive regulation of protein lipidation?
Initiation and substrate recognition
In simple terms: The process starts when enzymes recognize specific proteins that need to be lipid-modified.
Positive regulation of protein lipidation begins with the recognition of substrate proteins by lipidation enzymes such as palmitoyltransferases, farnesyltransferases, or N-myristoyltransferases. Regulatory proteins can enhance this step by increasing enzyme-substrate affinity or by recruiting substrates to specific membrane compartments. For instance, MPC1 regulates fatty acid synthase lactylation, a lipidation-like modification, by influencing metabolic flux and substrate availability. Similarly, CDK13 promotes lipid deposition by stimulating NSUN5-mediated m5C modification of ACC1 mRNA, which may indirectly enhance lipidation capacity.
Enzymatic activation and lipid transfer
In simple terms: Once the target is recognized, enzymes transfer lipid molecules onto the protein.
The core event in positive regulation of protein lipidation is the enzymatic transfer of lipid moieties to acceptor amino acids. This step can be positively regulated by allosteric activators, post-translational modifications of the lipidation enzymes, or changes in membrane lipid composition. For example, lipid overload-induced RTN3 activation promotes lipid droplet biogenesis, which may involve enhanced lipid transfer to proteins involved in droplet formation. Additionally, the membrane electric field regulates the PIP2-binding site to gate the KCNQ1 channel, illustrating how lipid-protein interactions can be modulated.
Membrane targeting and localization
In simple terms: After lipidation, the modified protein moves to membranes where it performs its function.
Lipidated proteins often translocate to specific membrane domains, such as the plasma membrane, endosomes, or lipid droplets. Positive regulation of protein lipidation can increase the efficiency of this targeting. For example, ApoA-I lipidation by ABCA1 is differentially regulated by Niemann-Pick type C1 in hepatocytes and macrophages, affecting cholesterol efflux and membrane remodeling. Similarly, p62 body-driven autophagosome formation requires local membrane source gathering, a process that depends on lipid modification and membrane dynamics.
Feedback and termination
In simple terms: The process is tightly controlled so that lipidation stops when it is no longer needed.
Positive regulation of protein lipidation is balanced by negative feedback mechanisms and depalmitoylases that remove lipid groups. Regulatory proteins can enhance or dampen the process in response to cellular signals. For instance, CD1 displays its own negative regulators, which may include lipid-modifying enzymes that fine-tune antigen presentation. Understanding these feedback loops is essential for therapeutic targeting of lipidation pathways.
Key Genes Involved in GO:1903061 positive regulation of protein lipidation
The following genes and proteins have been experimentally linked to the positive regulation of protein lipidation or related lipid modification processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MPC1 | Regulates fatty acid synthase lactylation and mitochondrial pyruvate metabolism | Implicated in nonalcoholic fatty liver disease; potential target for metabolic disorders |
| RTN3 | Promotes lipid droplet biogenesis under lipid overload | Linked to cardiac dysfunction; model for lipotoxicity |
| CDK13 | Stimulates NSUN5-mediated m5C modification of ACC1 mRNA | Promotes lipid deposition and prostate cancer progression |
| NSUN5 | RNA m5C methyltransferase that modifies ACC1 mRNA | Enhances lipid synthesis; cancer research target |
| ACC1 | Acetyl-CoA carboxylase 1, key enzyme in fatty acid synthesis | Regulated by m5C modification; target for lipid metabolism studies |
| ABCA1 | Mediates ApoA-I lipidation and cholesterol efflux | Regulated by NPC1; relevant to atherosclerosis |
| NPC1 | Niemann-Pick type C1 protein, regulates ABCA1 expression and ApoA-I lipidation | Differential regulation in hepatocytes and macrophages; disease model for Niemann-Pick type C |
| ApoA-I | Major apolipoprotein that accepts lipids from ABCA1 | Lipidation is critical for HDL formation; cardiovascular research |
| KCNQ1 | Potassium channel regulated by PIP2 binding | Membrane electric field regulates PIP2-binding site; cardiac arrhythmia research |
| p62 | Scaffold protein that drives autophagosome formation | Local membrane source gathering; autophagy and cancer research |
| CD1 | Antigen-presenting molecule that displays lipid antigens | Negative regulators of CD1; immunology and infection research |
| FASN | Fatty acid synthase, enzyme that produces fatty acids | Lactylation regulated by MPC1; target for NAFLD and cancer |
| PIP2 | Phosphatidylinositol 4,5-bisphosphate, membrane lipid | Regulates ion channels; lipidation-related signaling |
| Ras | Small GTPase that requires lipidation for membrane targeting | Model for protein lipidation in cancer; not directly cited but well-known |
| Rho GTPases | Family of GTPases modified by lipidation | Control cell migration and polarity; cancer and development |
| Palmitoyltransferases | Enzymes that attach palmitate to proteins | Key positive regulators of lipidation; drug targets |
| Farnesyltransferases | Enzymes that attach farnesyl groups to proteins | Targets for cancer therapy; regulate Ras localization |
How Is positive regulation of protein lipidation Regulated?
Positive regulation of protein lipidation is controlled at multiple levels. Metabolic signals such as lipid availability can activate enzymes like RTN3, which promotes lipid droplet biogenesis. Transcriptional and post-transcriptional mechanisms, such as CDK13-mediated m5C modification of ACC1 mRNA, enhance the expression of lipidation-related enzymes. Additionally, protein-protein interactions and membrane lipid composition, including PIP2 levels, can modulate the activity of lipidation enzymes and substrate accessibility. Feedback loops involving negative regulators, such as those affecting CD1, ensure that lipidation is tightly controlled.
positive regulation of protein lipidation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MPC1 | Nonalcoholic fatty liver disease | Hepatocyte-specific knockout mice, high-fat diet |
| RTN3 | Cardiac dysfunction | Cardiomyocyte-specific knockout or overexpression mice |
| CDK13 | Prostate cancer | Prostate cancer cell lines with CDK13 knockout, xenograft models |
| NPC1 | Niemann-Pick type C disease, atherosclerosis | NPC1-deficient mice, primary hepatocytes and macrophages |
| ABCA1 | Tangier disease, cardiovascular disease | ABCA1 knockout mice, cell-based cholesterol efflux assays |
Metabolic liver disease
MPC1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease (NAFLD). Dysregulation of protein lipidation contributes to hepatic steatosis and inflammation, making positive regulators of lipidation potential therapeutic targets. Experimental models include high-fat diet-fed mice and hepatocyte-specific knockout of MPC1.
Cardiac dysfunction
Lipid overload-induced RTN3 activation leads to cardiac dysfunction by promoting lipid droplet biogenesis. This suggests that excessive positive regulation of protein lipidation can be detrimental to heart function. Research models include cardiomyocyte-specific RTN3 knockout or overexpression in mice subjected to lipid overload.
Cancer
CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA. This links positive regulation of lipidation to oncogenic lipid metabolism. Experimental models include prostate cancer cell lines with CDK13 knockout or overexpression, and xenograft mouse models.
Cardiovascular and lipid disorders
ABCA1-mediated ApoA-I lipidation is differentially regulated by Niemann-Pick type C1 in murine hepatocytes and macrophages. This pathway is critical for HDL biogenesis and cholesterol efflux, and its dysregulation contributes to atherosclerosis. Models include NPC1-deficient mice and cell-based assays.
From positive regulation of protein lipidation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate protein lipidation? | CRISPR knockout of gene X followed by lipidation assays (e.g., click chemistry, Western blot) |
| What is the effect of a specific point mutation in a lipidation enzyme? | CRISPR point mutation knock-in in cell lines, followed by enzymatic activity assays |
| How does a disease-associated mutation affect lipidation? | Knock-in of the mutation in mice or patient-derived iPSCs, followed by lipidomics |
| Where does a lipidation regulator localize in cells? | Tagged knock-in (e.g., GFP) for live-cell imaging |
| Does overexpression of gene Y increase lipidation? | CRISPR activation (CRISPRa) or lentiviral overexpression, followed by lipidation quantification |
| Which genes regulate lipidation in a genome-wide manner? | CRISPR library screening with a lipidation reporter |
How to Study the positive regulation of protein lipidation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Click chemistry | Incorporation of tagged lipids into proteins | Detection and quantification of protein lipidation |
| Western blot | Protein levels and modification status | Validation of lipidation changes in knockout/overexpression models |
| Mass spectrometry | Identification of lipidated peptides and lipid species | Unbiased discovery of lipidation targets |
| Fluorescence microscopy | Subcellular localization of lipidated proteins and lipid droplets | Imaging of lipid droplet biogenesis and membrane targeting |
| CRISPR knockout | Loss-of-function effects on lipidation | Causal testing of candidate positive regulators |
| CRISPR activation | Gain-of-function effects on lipidation | Overexpression of candidate genes to enhance lipidation |
| RNA-seq | Transcriptional changes in lipidation pathways | Identifying downstream effects of lipidation regulators |
| Lipidomics | Global lipid profile changes | Assessing metabolic consequences of altered lipidation |
Biochemical assays for lipidation
Protein lipidation can be detected using click chemistry with azide- or alkyne-tagged lipids, followed by gel electrophoresis and Western blotting. This method allows direct visualization of lipidated proteins and quantification of changes in response to genetic perturbations.
Proteomics and lipidomics
Mass spectrometry-based proteomics can identify lipidated proteins and their modification sites, while lipidomics profiles the lipid species involved. These approaches are useful for unbiased discovery of positive regulators of protein lipidation.
Imaging and localization studies
Fluorescence microscopy with tagged proteins or lipid probes can reveal the subcellular localization of lipidated proteins and lipid droplets. Live-cell imaging is particularly useful for studying dynamic processes such as RTN3-mediated lipid droplet biogenesis.
CRISPR screening and bioinformatics
Genome-wide CRISPR knockout or activation screens coupled with lipidation reporters can identify novel positive regulators. Bioinformatics analysis of transcriptomic and proteomic data can reveal pathways and networks associated with GO:1903061.
How CRISPR Can Be Used to Study GO:1903061 positive regulation of protein lipidation
Knockout
CRISPR knockout of candidate genes such as MPC1, RTN3, or CDK13 can abolish their positive regulatory effects on protein lipidation, providing causal evidence. For example, MPC1 knockout in hepatocytes reduces fatty acid synthase lactylation and exacerbates NAFLD in mice. Similarly, RTN3 knockout in cardiomyocytes attenuates lipid droplet biogenesis and cardiac dysfunction.
Point Mutation
CRISPR point mutation knock-in can introduce specific amino acid substitutions to dissect the functional domains of lipidation regulators. For instance, mutating the catalytic site of NSUN5 would test its role in m5C modification of ACC1 mRNA and downstream lipid deposition. Point mutations in PIP2-binding sites of KCNQ1 can reveal how lipid interactions gate channel activity.
Knock-in
CRISPR knock-in of tags (e.g., GFP, HA) or disease-associated alleles allows tracking and functional analysis of lipidation regulators in their native genomic context. For example, knocking in a fluorescent tag on RTN3 enables live-cell imaging of lipid droplet dynamics. Knock-in of NPC1 mutations can model Niemann-Pick type C disease and its effects on ApoA-I lipidation.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can increase the levels of positive regulators to study gain-of-function effects. Overexpressing CDK13 in prostate cancer cells enhances NSUN5-mediated m5C modification and lipid deposition, promoting tumor progression. Overexpression of ABCA1 increases ApoA-I lipidation and cholesterol efflux.
How EDITGENE Supports positive regulation of protein lipidation Research
Researchers studying positive regulation of protein lipidation-related genes often need to determine whether a candidate gene is causally involved in lipid modification, and to dissect the precise molecular mechanisms. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations, knock-ins, overexpression, and high-throughput library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein lipidation research.
Frequently Asked Questions About positive regulation of protein lipidation
What is GO:1903061?
GO:1903061 is the Gene Ontology term for positive regulation of protein lipidation, defined as any process that activates or increases the frequency, rate or extent of protein lipidation.
What is protein lipidation?
Protein lipidation is the covalent attachment of lipid molecules to proteins, which controls their membrane localization, stability, and interactions.
What genes are involved in positive regulation of protein lipidation?
Key genes include MPC1, RTN3, CDK13, NSUN5, ACC1, ABCA1, NPC1, and ApoA-I, among others.
How is protein lipidation regulated?
It is regulated by metabolic signals, transcriptional and post-transcriptional mechanisms, and protein-protein interactions that modulate enzyme activity and substrate availability.
What diseases are associated with dysregulated protein lipidation?
Diseases include nonalcoholic fatty liver disease, cardiac dysfunction, prostate cancer, and atherosclerosis.
What methods are used to study positive regulation of protein lipidation?
Common methods include click chemistry, Western blot, mass spectrometry, fluorescence microscopy, CRISPR knockout/activation, RNA-seq, and lipidomics.
How can CRISPR be used to study protein lipidation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes that positively regulate lipidation.
What is the role of MPC1 in protein lipidation?
MPC1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease.
How does RTN3 affect cardiac function?
Lipid overload-induced RTN3 activation leads to cardiac dysfunction by promoting lipid droplet biogenesis.
What is the link between CDK13 and prostate cancer?
CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA.
Conclusion
GO:1903061, positive regulation of protein lipidation, is a critical biological process that controls the covalent attachment of lipids to proteins, influencing membrane targeting, signaling, and metabolism. Dysregulation of this process is implicated in metabolic liver disease, cardiac dysfunction, and cancer, making its regulators attractive therapeutic targets. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of novel positive regulators and their mechanisms. EDITGENE provides comprehensive services to support these research efforts, from gene knockout to library screening and bioinformatics.
References
- 1. Gao R et al.. 2023. Mitochondrial pyruvate carrier 1 regulates fatty acid synthase lactylation and mediates treatment of nonalcoholic fatty liver disease.. Hepatology 78(6):1800-1815 PMID: 36651176
- 3. Guo D et al.. 2024. Lipid overload-induced RTN3 activation leads to cardiac dysfunction by promoting lipid droplet biogenesis.. Cell Death Differ 31(3):292-308 PMID: 38017147
- 4. Zhang Y et al.. 2023. CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA.. Cell Death Differ 30(12):2462-2476 PMID: 37845385
- 5. Feng X et al.. 2023. Local membrane source gathering by p62 body drives autophagosome formation.. Nat Commun 14(1):7338 PMID: 37957156
- 6. Shahine A et al.. 2023. CD1 displays its own negative regulators.. Curr Opin Immunol 83:102339 PMID: 37245411
- 7. Mandala VS et al.. 2023. The membrane electric field regulates the PIP(2)-binding site to gate the KCNQ1 channel.. Proc Natl Acad Sci U S A 120(21):e2301985120 PMID: 37192161
- 8. Wang MD et al.. 2007. Differential regulation of ATP binding cassette protein A1 expression and ApoA-I lipidation by Niemann-Pick type C1 in murine hepatocytes and macrophages.. J Biol Chem 282(31):22525-33 PMID: 17553802
